Literature DB >> 7365520

Absorbed doses of radiation after an intravenous injection of N-13 ammonia in man: concise communication.

A H Lockwood.   

Abstract

Using body distribution data with the MIRD tables and equations, the radiation dose delivered by an i.v. injection of N-13 ammonia has been calculated for several human organs. The liver and the urinary bladder wall receive 0.017 and 0.051 rad/mCi injected respectively; the latter can be reduced by early post-injection voiding. The brain-to-brain absorbed dose is 0.016 rad/mCi injected. The absorbed doses for the whole body, the red marrow, the ovaries, and the testes are, respectively, 0.0055, 0.0054, 0.0098, and 0.0010 rad/mCi injected. Severe liver disease is associated with a reduction in the fraction of the injected N-13 that is excreted in the urine, and thus causes a reduction in the absorbed dose to the urinary bladder wall from the bladder contents. Hepatomegaly increases the fraction of the N-13 ammonia trapped by the liver, and complicates calculation of the absorbed dose of radiation. These data should facilitate the evaluation of the risk from radiation absorption following i.v. injections of N-13 ammonia in humans.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7365520

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  4 in total

1.  Quantification of the whole-body distribution of PET radiopharmaceuticals, applied to 3-N-([18F]fluoroethyl)spiperone.

Authors:  H Herzog; H H Coenen; T Kuwert; K J Langen; L E Feinendegen
Journal:  Eur J Nucl Med       Date:  1990

2.  PET radiopharmaceuticals in Europe: current use and data relevant for the formulation of summaries of product characteristics (SPCs).

Authors:  G J Meyer; S L Waters; H H Coenen; A Luxen; B Maziere; B Langström
Journal:  Eur J Nucl Med       Date:  1995-12

Review 3.  Searching for novel PET radiotracers: imaging cardiac perfusion, metabolism and inflammation.

Authors:  Caitlund Q Davidson; Christopher P Phenix; T C Tai; Neelam Khaper; Simon J Lees
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-06-05

4.  The combination of 13N-ammonia and 18F-FDG whole-body PET/CT on the same day for diagnosis of advanced prostate cancer.

Authors:  Chang Yi; Donglan Yu; Xinchong Shi; Xiangsong Zhang; Ganhua Luo; Qiao He; Xuezhen Zhang
Journal:  Nucl Med Commun       Date:  2016-03       Impact factor: 1.690

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.